The surge for safety in MS treatment
This article was originally published in Scrip
There are many promising candidates under development for multiple sclerosis, with a range of different mechanisms of action. Ian Schofield looks at what the pipeline may hold in the way of future treatments for this disabling and difficult-to-treat disease. .